Assignee
ANTEV LTD
GB·5 granted patents·4 pending applications·2 citations·filing 2018–2023
Top patents by PatentIndex Score
9 records- 0175US11719488B2Lyophilization process and a teverelix-TFA lyophilizate obtained therebyANTEV LTD·Filed 2019·Granted Aug 8, 2023·2 cites·13 claims
- 0272US12458680B2Reconstitutable teverelix-TFA compositionANTEV LTD·Filed 2023·Granted Nov 4, 2025·0 cites·10 claims
- 0368US12070484B2Teverelix-TFA compositionANTEV LTD·Filed 2022·Granted Aug 27, 2024·0 cites·14 claims
- 0468US2023358472A1Lyophilization process and a teverelix-tfa lyophilizate obtained therebyANTEV LTD·Filed 2023·Application pending·0 cites
- 0564US11633453B2Reconstitutable teverelix-TFA compositionANTEV LTD·Filed 2019·Granted Apr 25, 2023·0 cites·12 claims
- 0664US11357818B2Teverelix-TFA compositionANTEV LTD·Filed 2019·Granted Jun 14, 2022·0 cites·7 claims
- 0745US2020129583A1Composition for treating acute urinary retentionANTEV LTD·Filed 2018·Application pending·0 cites
- 0845US2018214506A1Combination administration of gnrh antagonistsANTEV LTD·Filed 2018·Application pending·0 cites
- 0945US2020000872A1A composition comprising at least one gnrh antagonistANTEV LTD·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →